FERTIN
LIVE

Serial Number

98065183

Owner

Fertin Pharma A/S

Attorney

Tamar Niv Bessinger

Filing Date

Jun 29, 2023

Add to watchlist:

No watchlists yet
View on USPTO

FERTIN Trademark

Serial Number: 98065183

FERTIN is a trademark filed by Fertin Pharma A/S on June 29, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Fertin Pharma A/S (19 trademarks)

Industrivej 8

Entity Type: 16

Trademark Details

Filing Date

June 29, 2023

Registration Date

Not Registered

Published for Opposition

December 10, 2024

Goods & Services

Pharmaceutical preparations for smoking cessation; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of insomnia and sleep disorders, and to improve quality and quantity of sleep; pharmaceutical preparations to treat fever; pharmaceutical preparations to treat inflammation; Pharmaceutical preparations for the treatment of arthritis; psychotherapeutic pharmaceutical preparations; pharmaceutical preparations for treatment of cold; Pharmaceutical preparations for treatment of flu; Pharmaceutical preparations for treatment of cough; Pharmaceutical preparations for treatment of sinus; Pharmaceutical preparations for treatment of allergy; Pharmaceutical preparations for treatment of cardiovascular diseases; Pharmaceutical preparations for treatment of neurological disorders; Pharmaceutical preparations for treatment of chronic pain; Pharmaceutical preparations for treatment of gastro-intestinal disorders; vitamins; dietary supplements prepared from fruit extracts; dietary supplements prepared from vegetable extracts; dietary supplements prepared from herbal extracts; dietetic supplements prepared from herbal extracts; dietetic supplements prepared from fruit extracts; dietetic supplements prepared from vegetable extracts; nicotine chewing gum for use as aid to stop smoking; medicated chewing gum; dietetic substances adapted for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes

Research and development of technology in the field of smoking cessation preparations; research and development of technology in the field of analgesics; research and development of technology in the field of sleep aid drugs; research and development of technology in the field of anti-pyretic drugs; research and development of technology in the field of anti-inflammatory preparations; research and development of technology in the field of pharmaceutical preparations for the treatment of arthritis; research and development of technology in the field of psychotherapeutic preparations; research and development of technology in the field of pharmaceutical preparations for treatment of cold; research and development of technology in the field of pharmaceutical preparations for treatment of flu; research and development of technology in the field of pharmaceutical preparations for treatment of cough; research and development of technology in the field of pharmaceutical preparations for treatment of sinus; research and development of technology in the field of pharmaceutical preparations for treatment of allergy; research and development of technology in the field of pharmaceutical preparations for treatment of cardiovascular diseases; research and development of technology in the field of pharmaceutical preparations for treatment of neurological disorders; research and development of technology in the field of pharmaceutical preparations for treatment of chronic pain; research and development of technology in the field of pharmaceutical preparations for treatment of gastro-intestinal disorders; design of new products for others; scientific and technological services in the nature of testing of new products for others; medical research services; scientific research services; pharmaceutical products development; formulation of inhaled therapeutics; research and development of inhaled therapeutics; formulation of pharmaceuticals for oral and intra-oral delivery systems; research and development of pharmaceuticals for oral and intra-oral delivery systems

Custom manufacture of pharmaceuticals and nutraceuticals; consultancy regarding the custom manufacture of pharmaceuticals and nutraceuticals; provision of advice, information and consultancy in relation to the aforesaid services

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 28, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 28, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 26, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 25, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 25, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 25, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 14, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 14, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 14, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 14, 2024 CNEA
ASSIGNED TO EXAMINER
Nov 6, 2024 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 23, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 23, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 23, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2023 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 5, 2023 PARI
NEW APPLICATION ENTERED
Jul 3, 2023 NWAP